Warning letter
First Priority, Inc.: warning letter of Jul 9, 2007
FDA warning letter UCM076439 · Chicago District Office
Key facts
| Reference number | UCM076439 |
|---|---|
| Company | First Priority, Inc. |
| Subject | CGMP Regulation for Finished Pharmaceuticals/Adulterated |
| Issue date | Jul 9, 2007 |
| Posted date | Jul 9, 2007 |
| Issuing office | Chicago District Office |
| Product type | Drugs |
| CFR sections cited | 211.192, 500.30, 211.22(d), 211.110(a), 211.160(a), 211.160(b)(3), 211.165(a), 211.198(a) |
| Country | 3 |
| Inspection city | Elgin |
| Inspection ZIP | 60123-1287 |
| Inspection start date | Oct 24, 2006 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: